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1. Introduction 
Non-herpetic acute limbic encephalitis (NHALE) was found at 1994 during the survey of 
herpes simplex encephalitis (HSE) in the Kyushu district, Japan. NHALE is characterized by 
a lack of evidence of the herpes simplex virus (HSV) genome or HSV antibody, non-
paraneoplastic limbic encephalitis, and magnetic resonance imaging (MRI) abnormalities in 
bilateral medial temporal lobes such as the hippocampi and amygdalae (Kusuhara et al., 
1994; Kaji et al., 1996; Shoji et al., 2004). Etiologies of NHALE consist of various causes, 
including viral origins, autoimmune disorders, and several anti-neural antibodies. Since 
Urgent Conference on Non-Herpetic Limbic Encephalitis, at Ichikawa City, Japan, 
November 2002, many cases have been accumulated as viral related acute limbic 
encephalitis, autoantibody-mediated acute limbic encephalitis, paraneoplastic limbic 
encephalitis or encephalopathy (Yuasa et al, 2003). Cerebrospinal fluid (CSF) shows a mild 
pleocytosis with increase of pressure, mild increase of protein, and sometimes, a lack of the 
pleocytosis. The CSF level of interferon-γ (IFN-γ) is unchanged with an increase of 
interleukin (IL)-6 (Asaoka et al., 2004; Ichiyama et al., 2008a). Among them, NHALE patient 
group with the onset symptoms of abnormal behavior and incoherence, and the detection of 
anti-glutamate receptor (GluRε2 NR2B) antibodies is gaining attention (Nemoto et al., 2005; 
Hayashi et al. 2005; Takahashi et al., 2007). This NHALE type is indicated to form a new 
subgroup of acute limbic encephalitis or encephalopathy. GluRε2 is a subunit of the N-
methyl-D-asparate (NMDA) glutamate receptor. NHALE overlaps clinically to anti-NMDA 
receptor (NR1+2A) encephalitis, but the NMDA encephalitis is usually associated with 
ovarian teratoma (Dalmau et al., 2007; Iizuka et al., 2008).  
In this review, two NHALE patients with positive anti-GluRε2 antibody are briefly 
described, and the pathogenesis of NHALE, clinical features, differential diagnosis, 
prognosis, and sequelae are discussed. 
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Fig. 1. Possible relationships of NHALE and related disorders. 
NHALE=non-herpetic acute limbic encephalitis, NMDAR=N-methyl-D-asparate receptor 
VGKC =voltage-gated potassium channel, LE=limbic encephalitis 
2. Case presentation 
Here, we present two representative patients with NHALE who were evaluated at A 
rehabilitation hospital 3 months to 2 years after the onset (Noto et al., 2008; Shoji et al., 2009). 
Patient 1: A 50 year-old man was restless and became talkative with a fever and palpitation 
in the end of July 200x. Several days later, he was admitted with collapsed state to a nearby 
hospital. On admission, he showed a fever of 38.4℃, coma state, and generalized myoclonus 
without nuchal stiffness, then paroxysmal atrial fibrillation, status epileptics, and needed an 
artificial respirator for 3 months. The CSF exhibited no abnormalities in the cell count, 
protein and glucose contents, and polymerase chain reaction (PCR) for HSV and human 
herpesvirus (HHV)-6 was negative. The serum antibodies were negative for herpesvirus 
groups (HSV, HHV-6, varicella-zoster virus and cytomegalovirus). The MRI revealed 
hyperintensity lesions bilaterally in the hippocampi, amygdalae and claustrum. His CSF at 
the 5th illness day was positive for anti-GluRε2 IgG and IgM antibodies. Acyclovir (ACV) 
administration, thereafter methylprednisolone pulse therapy was performed with sodium 
valproate and clonazepam. Amnestic syndrome and partial seizure remained. Three months 
after the onset he was transferred to A rehabilitation hospital which was near to his home 
town. Neuropsychological tests such as the Wechsler adult intelligence scale-revised 
(Japanese edition, WAIS-R), Wechsler memory scale-revised (Japanese edition, WMS-R), 
and functional independence measure (FIM) were conducted to assess the sequelae for 2 
years after the onset. WMS-R showed severe impairment of recent memory with normal 
total WAIS IQ and FIM points. The MRI at the recovery stage showed bilateral atrophic 
changes in the hyppocampi and amygdalae with hyperintensity lesions in the rectus gyri 
(Fig 2a). Thereafter, he moved to an another rehabilitation hospital. At 2 years after the 
onset, moderate amnestic syndrome and focal seizure remained, and he is still unable to 
return to his previous job. 
Patient 2: A 36 year-old man had diarrhea for several days, and he then developed a fever of 
40℃ for one week, but he did not stop his job of rescue party. Convulsive seizures and 
delirium appeared, and he was admitted to a nearby hospital. His consciousness level was 
stupor state without nuchal stiffness and pathologic reflexes. The CSF contained 6 
mononuclear cells per mm3 and protein content of 46 mg/dl, and HSV PCR was negative in 
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the CSF. Serum enzyme immunosorbent assay (EIA) tests for herpesvirus groups, rubella, 
measles and mumps were all negative. His CSF showed positive for anti-GluRε2 IgG and 
IgM antibodies. Electroencephalogram (EEG) revealed periodic lateralized epileptiform 
discharges (PLEDs). The MRI exhibited hyperintensity lesions in the bilaterally medial 
temporal lobes including  hippocampi and amygdalae. Patient 2 was diagnosed as having 
NHALE with positive anti-GluRε2 antibodies. Anticonvulsant drugs and ACV were 
administered, but he developed status epileptics, and put on a respirator, and 
methylpredonisolone pulse and immunoglobulin therapies were conducted. Three months 
after the onset, he was transferred to A rehabilitation hospital. He showed a fever of 37ºC, 
attention impairment, nystagmus, myoclonus at the left face and upper extremity, and 
weakness and atrophy of the both legs as a disuse syndrome. MRI revealed bilaterally 
atrophy of the hippocampi and amygdalae with hyperintensity lesions (Fig.2b). WAIS-R 
showed 69 of total IQ, and 44/126 at FIM. Intensive rehabilitation was performed, and 6 
months later he was discharged with improvement of scores of WAIS-R, WMS-R and FIM. 
At 2 years after the onset, mild dysarthria, attention impairment, and gait disturbance have 
remained, and he is now trying to return to his previous job. 
 
 
Fig. 2. a,b: MRIs of Patients 1 & 2 with NHALE at the recovery stage; a: an axial fluid 
attenuated inversion recovery (FLAIR) MRI of Patient 1 reveals hyperintensity lesions in the 
rectus gyri, and mild dilatation of the inferior horn. b: an axial FLAIR MRI of Patient 2 
shows moderate dilatation of the inferior horn. 
3. Pathogenesis 
In the CSF cytokines of NHALE patients, the IFN-γ value is not elevated with an increase of 
IL-6 (Asaoka et al., 2004; Ichiyama et al., 2008a; Fig.3). CSF IFN-γ levels were elevated in the 
central nervous system (CNS) disorders due to direct viral invasion, such as viral meningitis 
and HSE (Matsubara et al., 2000; Ichiyama et al., 2005; Ichiyama et al., 2008a), but not in 
immune-mediated CNS disorders, such as acute disseminated encephalomyelitis, influenza-
associated encephalopathy, and acute encephalopathy following prolonged febrile seizures, 
and hemolytic uremic syndrome with encephalopathy (Ichiyama et al., 2002; Ichiyama et al., 
2004; Ichiyama et al., 2008b; Shiraishi et al., 2008). IFN-γ, which is produced by NK cells, 
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CD8+ and Th1 type CD4+ T lymphocytes, plays an important role in host defense against 
viral infection, and inhibits viral replication (Samuel., 1991). Therefore, IFN-γ elevating in 
the CSF may exert an inhibitory effect against viruses invading the CNS. With respect to 
CSF IFN-γ levels, we suggest that the main pathogenesis of NHALE is not caused by the 
direct invasion of virus into the CNS.  
 
 
Fig. 3. The CSF concentrations of IFN-γ, IL-6, IL-10, and sTNFR1 in patients with NHALE, 
HSE, and controls. Horizontal lines indicate geometric means. Shaded areas indicate values 
below the detection limits. IFN-γ=interferon-γ, IL=interleukin, sTNFR1=soluble tumor 
necrosis factor receptor-1 
In a major subgroup of NHALE patients presenting psychiatric symptoms such as abnormal 
behavior or incoherence, a subunit of NMDA glutamate receptor antibody (GluRε2 NR2B) 
was detected in the sera and CSF. In Japan, many similar cases have been accumulated 
(Nemoto et al., 2005; Hayashi et al., 2005; Noto et al., 2008). Patients 1 & 2 here described are 
regarded as anti-GluRε2 positive NHALE. Mochizuki et al. (2006) reported an autopsy case 
of NHALE with positive Anti-GluRε2 NR2B antibody, and a few autopsy cases followed 
(Okamoto et al., 2008; Maki et al., 2008). Thus, this NHALE type should be regarded as 
belonging to a new subgroup of acute limbic encephalitis. Anti-NMDA type GluR 
antibodies categorized into NMDA glutamate receptor complex antibodies {GluR1 (NR1) + 
GluR1 (NR2A) or GluR2 (NR2B)} and antibodies to each subunits composing of the 
complex antibodies. Antibodies to GluRε2 (NR2B) subunit are antibodies to a whole 
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molecules of GluRε2 (NR2B) subunit (Takahashi et al., 2008, Fig.4). Takahashi et al. (2008) 
reported 60% positive rate of Anti-GluRε2 antibodies in the serum of NHALE patients from 
the acute to convalescent stage, whereas these Anti-GluRε2 antibodies in the CSF of NHALE 
patients were detected in 50% at the acute stage, and 40% at the recovery stage; anti-GluRε2 
antibodies is indicated to invade from serum to CNS with injury of the blood-brain barrier, 
and may involve the pathogenesis of acute limbic encephalitis or encephalopathy 
(Takahashi et al., 2007; 2010). Ichiyama et al. (2009) reported that high matrix 
metalloproteinase-9/tissue inhibitor of metalloproteinase 1 (MMP-9/TIMP-1) ratio which 
indicates to injure the blood-brain barrier continues from the acute to convalescent stages 
(Fig. 5).  
 
 
Fig. 4. Antibodies to NMDA-type GluR complex and each domain of GluR subunits. 
Antibodies to NMDA-type GluR complex (antibodies to NMDAR) were examined using 
HEK cells transfected by expression plasmid of GluR1 (NR1) + GluR1 (NR2A) or GluR2 
(NR2B) (Dalmau et al., 2007). Antibodies against whole molecules of GluRε2 were examined 
by immunoblot (Takahashi Y et al., 2003). Antibodies against each domain of GluRε2 
(NR2B) and GluR1 (NR1) were examined by ELISA with synthesized peptides. NMDA=N-
methyl-D-asparate, GluR= glutamate receptor 
On the other hand, the anti-GluR ε2 antibodies are also detected in Rasmussen encephalitis, 
acute encephalitis with refractory repetitive partial seizures (AERRPS), mild encephalopathy 
with a reversible splenial lesion (MERS), or HSE (Takahashi et al., 2003; 2005; Sakuma et al., 
2009; Kai et al., 2009). Anti-GluRε2 antibody encephalitis may form a wider spectrum of 
encephalitis and encephalopathy. The antibody reacts cross to anti-NMDA-type GluR 
complex antibodies, and the clinical significance and specificity to NHALE of anti-GluRε2 
antibodies is not established. In near future, the specificity, or further pathological 
mechanism of GluRε2 NR2B for NHALE should be investigated. 
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Fig. 5. Serum concentrations of MMP-9 and TIMP-1 and the ratio of MMP-9/TIMP-1 in 
patients with NHALE and in controls. The high ratio of MMP-9/TIMP-1 continues from the 
acute to convalescent stages. A: Patients with NHALE in the acute stage, B: patients with 
NHALE in the convalescent stage, and C: controls. The horizontal lines indicate median 
values. MMP-9=matrix metalloproteinase-9 , TIMP-1=tissue inhibitor of metalloproteinase 1  
4. Clinical characteristics  
4.1 Clinical findings 
Incidence rate is 4.7 persons per million person-year. Mean onset ages of NHALE show 44.8 
years in male and 31.6 years in female, respectively (Wada-Isoe et al., 2008). 
In response to the limbic system disorder, various symptoms such as changeable 
disorientation, memory impairment, catalepsy, schizophrenic-like delusions, anger, 
hallucinations, convulsive seizures, autonomic seizures, pulse rate or respiratory 
abnormalities, and hyponatremia can appear (Yuasa, 2003). Our Patients 1 & 2 showed 
restlessness, palpitation and delirious state as initial symptoms. In the acute stage of 
NHALE, schizophrenic-like symptoms consisting of abnormal behavior, incoherence, 
delusions, and hallucination are frequently observed, and then convulsive seizures, status 
epileptics, and autonomic seizures are follows. Meningeal irritation signs appear mildly. 
Takahashi et al. (2008) analyzed 53 cases of non-paraneoplastic non-herpetic acute limbic 
encephalitis compared with 16 negative anti-GluRε2 antibody cases; abnormal behavior, 
delusions, and hallucination are more frequently observed including autonomic seizures, 
pyramidal and extrapyramidal signs, and cerebellar symptoms. Status epileptics appeared 
at 56.5% of the adult cases, and the other complexes partial seizures without convulsive 
seizure are also described. Prognostic outcome is comparative favorable, and several limited 
autopsy cases have been reported (Mochizuki et al., 2006). As the complications of NHALE, 
hypertrophic pachymeningitis or Vogt-Koyanagi-Harada disease has been reported (Usui et 
al., 2007; Masuda et al., 2009). 
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4.2 Laboratory findings 
PCR and antibody tests including sensitive enzyme-linked immunosorbent assay for 
herpesvirus groups result in all negative. However, in the serum tests of the adults or 
elderly patients we may sometimes encounter carrier having HSV positive antibody (Shoji et 
al., 2004).   
CSF shows a mild pleocytosis with increase of pressure, mild increase of protein, and 
sometimes, a lack of the pleocytosis. The CSF level of IFN-γ is unchanged with an increase 
of IL-6 (Asaoka et al., 2004; Ichiyama et al., 2008a). Ichiyama et al. (2008a) reported the 
comparison of CSF cytokines between NHALE and HSE; increases of IFN-γ, IL-6, IL-10, and 
sTNFR were observed in HSE, whereas only increase of IL-6 was found in NHALE. Brain 
MRI exhibits often bilateral abnormalities in the limbic areas; abnormal signals distribute in 
the bilateral hippocampi, amygdalae, rectus, cingulated gyri, and insula. Diffusion weighted 
images (DWI) is most sensitive to detect the lesions, and the hyperintensity lesions 
decreased by apparent diffusion coefficient (ADC) (Fig.6). Brain CT is difficult to detect the 
medial temporal lesions. Also, it should be evaluated that the hyperintensity lesions are apt 
to appear by DWI as similar lesions after status epilepticus. At the acute stage the inferior 
horn narrowing is often observed by MRI or CT probably reflecting the brain edema, and at 
the recovery stage the inferior horn is dilated suggesting the brain atrophy. 99mTc-ECD using 
easy z-score imaging system (eZIS) analysis single photon emission CT (SPECT) may reveal 
wider hypo- or hyper-perfusion lesions than the corresponding MRI lesions in the limbic 
areas (Fig. 7). Moreover, the hyperintensity lesions on DWI may show relatively increased 
regional cerebral blood flow (rCBF) on eZIS analysis. EEG reveals whole moderate slowness, 
and PLEDs or periodic synchronous discharges (PSD) are observed at approximately 20-30% 
for the acute stage. 
 
 
Fig. 6. MRIs of patient with NHALE at the acute stage.  
Diffusion-weighted MR images showed hyperintensity lesions in the bilateral medial 
temporal lobes, cingulate gyri, and insulas.  
NHALE=non-herpetic acute limbic encephalitis  
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4.3 Treatment 
There is no standard therapy for NHALE. Most treatment approaches have employed some 
form of nonspecific immunosuppressant therapy similar to that used for other 
encephalitis/encephalopathy and autoimmune diseases, including corticosteroid, 
intravenous immunoglobulin (IVIg), plasmapheresis, or a combination of these therapies. 
High-dose intravenous steroids are widely accepted as first-line therapy. Most of the data 
describing treatment for NHALE are derived from case reports and small series. To date, 
there have been no randomized, controlled trials for the treatment of NHALE. On the other 
hand, ACV therapy is usually conducted at the acute stage due to difficulty to exclude HSE.  
 
 
Fig. 7. eZIS images in (axial view) patients with NHALE at acute stage. 
The eZIS analysis detected a significantly increased rCBF in the bilateral medial temporal 
lobes, left insula, and left putamen, and a significantly decreased rCBF in the bilateral 
frontal lobes. The color images represent the statistical significance (Z-score) of the increase 
(red) or decrease (blue) in rCBF. 
eZIS =easy z-score imaging system, NHALE=non-herpetic acute limbic encephalitis, 
rCBF=regional cerebral blood flow 
4.4 Differential diagnosis  
Differential diagnosis with HSE is important in the choice of anti-viral drug starting or 
immunological therapy. HSE presents a fever, meningeal irritation signs, consciousness 
impairment, convulsive seizures, and memory impairment, while NHALE shows the onset 
symptoms with abnormal behavior or talk, and meningeal signs appear mildly. 
Neuroimaging of HSE often involves predominantly unilateral temporal lobe, but NHALE 
tends to localize bilateral medial temporal lobes. The CSF findings of NHALE are apt to 
reveal mild changes. Differentiation between NHALE and NMDAR encephalitis at the 
initial stage may be difficult, because 25% of NMDAR encephalitis exhibits localized limbic 
encephalitis form (Iizuka et al., 2008). Therefore, particularly in juvenile female patients with 
acute encephalitis, ovarian teratoma should be checked rapidly (Kamei S., 2004, 2008). On 
the other hand, anti-voltage-gated potassium channel (VGKC) antibody limbic encephalitis 
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shows often encephalopathy type with hyponatremia, and overlaps Morvan syndrome with 
neuromyotonia. Hashimoto encephalopathy should be noticed to present limbic 
encephalopathy type, although this encephalopathy usually shows whole encephalitis type. 
5. Sequelae 
As sequelae, memory impairment, and personality or emotional changes have been most 
frequently described. Regards with the sequelae of our Patients 1 & 2 at 2 years after the 
onset, Patient 1 shows prominent impairment for recent memory with intact intelligence and 
immediate memory. Another Patient 2 presents memory and intelligence impairments, 
involuntary movement, and paresis in both legs as disuse syndrome. They are still unable to 
return their previous jobs.  
Next, we analyzed the sequelae evaluated in questionnaires from 19 cases of NHALE and 13 
cases of anti- NMDAR encephalitis, which was registered for an encephalitis research group 
of Japanese Ministry of Health & Welfare (Shoji et al., 2010). The Barthel score contains 
activity of daily living (ADL 0-20), epilepsy (0-4), psychosis (0-2), intelligence (0-4), memory 
impairment (0-2), and motor function (0-3) were assessed at 3 months and 1 year after the 
onset. Average ages of the NHALE and anti-NMDAR encephalitis groups were mean ± 
SD=37.5 ± 17.5 and 29.4 ± 3.2 years, respectively. Male and female ratio was all women in 
the NMDAR encephalitis. The statistical significance was evaluated using the Wilcoxon test. 
P values less than 0.10 were considered significant, because of the small case study for both 
groups.  
 
 
 
 
Fig. 8. The comparison of sequelae between NHALE and anti-NMDAR encephalitis 
(average/full score%). 
NHALE1= non-herpetic acute limbic encephalitis; 3 months after the onset, NHALE2=1 year 
after the onset, NMDAR1=anti- N-methyl-D-asparate receptor encephalitis; 3 months after 
the onset, NMDAR2=1 year after the onset, ADL=activity of daily living.  
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In the comparison between NHALE and NMDAR groups at 3 months after onset, in 
NHALE group memory impairment most frequently involved, while in NMDAR group 
ADL, intelligence and memory impairments severely disturbed (Fig. 8, p=0.055 by Wilcoxon 
test). These results may suggest that NHALE has a localized limbic lesion with comparative 
good prognosis, and NMDAR may represent whole brain encephalitis. However, the 
comparison between 3 months and 1 year after onset in both groups showed significant 
improvement in NMDAR than NHALE group (p=0.068 by Wilcoxon test).  
Prognostic outcome of NHALE is relatively favorable compared with HSE. However, many 
patients with NHALE are unable to return to their jobs because of memory impairments, 
and personality or emotional changes. Further collaborative investigation for the sequelae of 
NHALE and related disorders are expected. 
6. Conclusion 
Etiologies of NHALE consist of various causes, including viral origins, collagen disorders, 
and several anti-neural antibodies. Among them, anti- GluRε2 NR2B antibodies were 
detected. This NHALE type is indicated to form a new subgroup of acute limbic encephalitis 
or encephalopathy. The NHALE type may be characterized by the onset of abnormal 
behavior or incoherence, positive anti-GluRε2 NR2B antibodies, a lack of evidence of the 
HSV genome or HSV antibody, non-paraneoplastic limbic encephalitis, and MRI 
abnormalities predominantly in bilateral limbic systems, including hippocampi and 
amygdalae. CSF shows a mild pleocytosis, and sometimes, a lack of the pleocytosis. The CSF 
level of IFN-γ is not elevated with an increase of IL-6. The CSF cytokines’ profile suggests 
that the main pathogenesis of NHALE is not caused by the direct invasion of virus into the 
CNS. 
Prognostic outcome is relatively favorable, and differential diagnosis with HSE is important 
in the choice of anti-viral drug starting or immunological therapy. Furthermore, the 
specificity and pathological role of GluRε2 NR2B antibodies for NHALE should be 
investigated. 
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Many infectious agents, such as viruses, bacteria, and parasites, can cause inflammation of the central
nervous system (CNS). Encephalitis is an inflammation of the brain parenchyma, which may result in a more
advanced and serious disease meningoencephalitis. To establish accurate diagnosis and develop effective
vaccines and drugs to overcome this disease, it is important to understand and elucidate the mechanism of its
pathogenesis. This book, which is divided into four sections, provides comprehensive commentaries on
encephalitis. The first section (6 chapters) covers diagnosis and clinical symptoms of encephalitis with some
neurological disorders. The second section (5 chapters) reviews some virus infections with the outlines of
inflammatory and chemokine responses. The third section (7 chapters) deals with the non-viral causative
agents of encephalitis. The last section (4 chapters) discusses the experimental model of encephalitis. The
different chapters of this book provide valuable and important information not only to the researchers, but also
to the physician and health care workers.
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